Last updated on February 2020

A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)

Brief description of study

The purpose of this study is to see if the study drug, tirzepatide administered once weekly, is safe and effective as a treatment for Nonalcoholic Steatohepatitis (NASH).

Clinical Study Identifier: NCT04166773

Find a site near you

Start Over

Hirakata kohsai Hospital

Higashi-cho, Hirakata-city, Japan
  Connect »